GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In this study, investigators were seeking to uncover potential genetic correlations between hidradenitis suppurativa and ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

People with chronic kidney disease, Type 2 diabetes or both were predicted to have elevated cardiovascular disease (CVD) risk 8 to 28 years sooner than someone without those conditions, according to a ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

People with chronic kidney disease (CKD), Type 2 diabetes, or both were predicted to have elevated cardiovascular disease (CVD) risk from eight to 28 years sooner than someone without those conditions ...

Heart disease, Type 2 diabetes, high blood pressure and obesity were more common and linked to reduced access to healthy foods among people who live in neighborhoods previously subjected to redlining, ...

Obesity contributes to the risk of this form of heart disease by increasing cholesterol levels, promoting high blood pressure ...

But men with both conditions develop heart problems 28 years earlier, and women 26 years earlier MONDAY, Nov. 11, 2024 ...

Excess sugar links to many health risks. Learn how to cut back and replenish energy levels, prevent chronic diseases, and improve overall health.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...